Search Within

Michael Vincent Ortiz

Formats
  1. Journal Article (37)
  2. Meeting Abstract (20)
  3. Review (6)
  4. Editorial (3)
Groups
  1. Pediatrics, Department of (66)
  2. Sarcoma Service (Pediatrics) (66)
  3. Center for Hematologic Malignancies (33)
  4. Tow Center for Developmental Oncology (TCDO) (24)
  5. Sloan Kettering Institute Postdocs (21)
  6. GSK Faculty (20)

More Groups

People
  1. Emily Slotkin (16)
  2. Julia Glade Bender (16)
  3. Filemon Dela Cruz (14)
  4. Andrew Kung (13)
  5. Neerav Shukla (13)
  6. Alex Kentsis (11)

More People

Years
  1. 2025 (5)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. Pediatric Blood and Cancer (18)
  2. Journal of Clinical Oncology (7)
  3. Cancer Research (5)
  4. Clinical Cancer Research (3)
  5. JCI Insight (3)
  6. Cancer (2)

More Publications

Publishers
  1. Wiley Periodicals, Inc (18)
  2. American Association for Cancer Research (11)
  3. American Society of Clinical Oncology (9)
  4. Nature Publishing Group (6)
  5. Amer Soc Clinical Investigation Inc (3)
  6. Elsevier Inc. (3)

More Publishers

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting of the nuclear export protein XPO1 represents a non-genetically encoded vulnerability in malignant rhabdoid and Wilms tumors
    Meeting Abstract

    Coutinho, D. F.; Burke, C.; Mundi, P.; Ortiz, M. V.; Vallance, K. L.; Long, M.; Rosales, N.; Ibanez, G.; Marks, L. J.; Diolaiti, D.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting Bcl-xL in fibrolamellar hepatocellular carcinoma
    Meeting Abstract

    Shebl, B.; Lalazar, G.; Ng, D.; Finkelstein, T.; Zheng, G.; Zhang, P.; Rosemore, C.; Ortiz, M.; Zhou, D.; Simon, S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A single institutional experience using romiplostim to manage treatment related thrombocytopenia in pediatric solid tumor patients
    Meeting Abstract

    Degliuomini, M.; Armstrong, K.; Curry, M.; Mauguen, A.; Modak, S.; Dunkel, I.; Mones, J.; Ortiz, M.
    Blood (2022)

    Fulltext@MSK | Save
  • The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms
    Journal Article

    Dermawan, J. K.; Singer, S.; Tap, W. D.; Nacev, B. A.; Chi, P.; Wexler, L. H.; Ortiz, M. V.; Gounder, M.; Antonescu, C. R.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Named patient program use of PEDMARK™ to reduce the risk of cisplatin-induced ototoxicity in pediatric patients with localized solid tumors
    Meeting Abstract

    Brock, P.; Barone, G.; Boztug, H.; Mori, M.; Ortiz, M.; Bhattacharya, A.; Morgan, A.; Baskin-Bey, E.; McVey, D.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Post-chemotherapy blastemal-predominant Wilms tumor in the Children's Oncology Group (COG) context: Pooled outcomes data from studies AREN0532, AREN0533 AND AREN03B2
    Meeting Abstract

    Evageliou, N.; Renfro, L.; Vallance, K.; Varela, C.; Benedetti, D.; Perlman, E.; Cost, N.; Ehrlich, P.; Kalapurakal, J.; Khanna, G.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
    Journal Article

    Coutinho, D. F.; Mundi, P. S.; Marks, L. J.; Burke, C.; Ortiz, M. V.; Diolaiti, D.; Bird, L.; Vallance, K. L.; Ibáñez, G.; You, D.; more...
    Med (2022)

    Fulltext@MSK | Save
  • Leveraging circulating tumor DNA to optimize the initial management of childhood renal tumors
    Editorial

    Ortiz, M. V.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
    Journal Article

    Shebl, B.; Ng, D.; Lalazar, G.; Rosemore, C.; Finkelstein, T. M.; Migler, R. D.; Zheng, G.; Zhang, P.; Jiang, C. S.; Qureshi, A.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save